Woodline Partners »

Silverback Therapeutics shares owned by Woodline Partners

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Woodline Partners from 13F filings

Historical chart of Woodline Partners investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Woodline Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Woodline Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $14M 986k 14.50
2024-06-30 $2.4M 281k 8.51
2024-03-31 $4.1M 402k 10.22
2023-09-30 $3.2M 847k 3.78
2023-06-30 $4.5M 670k 6.70
2023-03-31 $3.9M 600k 6.51
2022-12-31 $11M 1.3M 8.53
2022-09-30 $4.3M 813k 5.28
2022-03-31 $293k 84k 3.51
2021-12-31 $3.3M 494k 6.66
2021-09-30 $4.2M 425k 9.98
2021-06-30 $12M 378k 30.89
2021-03-31 $9.0M 207k 43.63
2020-12-31 $10M 216k 46.34